NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
Back to search
Official data from USPTO
E&S HEALTHCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
E&S HEALTHCARE
ST13
US500000090031610Class
5, 10
Filing
90031610
Registration
7602896
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
12/17/2024
Trademark type
Word
Nice classes
5, 10
Filing date
07/01/2020
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Daejeon, KR
Examiner
PERKINS, ELLEN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
E&S Healthcare Co., Ltd.
Representatives
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents for medical use for immune disease; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; immunoassay diagnostic reagents for medical purposes; biological reagents for medical purposesbiological reagents for medical diagnostic purposes; reagents for medical diagnostic purposes for the analysis of body fluids; reagent paper for medical purposes; medicated lozenges; chemical reagents for medical purposes; diagnostic reagents for medicinal use; clinical medical reagents; clinical diagnostic reagents in the nature of clinical medical reagents
Class 10
Medical device for detecting cancer; medical devicein vitro diagnostic medical device for detecting breast cancer by Thioredoxin 1(Trx1) expression level; medical device for breast cancer detection for medical usenamely breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposesanti-Thioredoxin 1(Trx 1) antibody coated 96-well plateTrx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatus for detecting cancer and testing for viruses; apparatus for blood testing for medical use; medical device and apparatus in the field of clinical diagnosisa breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposesantiThioredoxin 1(Trx 1) antibody coated 96-well plateTrx 1 calibrator and anti-Trx 1 detection antibody; testing instruments for medical diagnostic purposesa breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposesanti-Thioredoxin 1(Trx 1) antibody coated 96-well plateTrx 1 calibrator and anti-Trx 1 detection antibody; tools for medical diagnosticsa breast cancer diagnostic kit comprised of serum collection empty enzyme-linked immunosorbent assay (ELISA) plate for medical purposesanti-Thioredoxin 1(Trx 1) antibody coated 96-well plateTrx 1 calibrator and anti-Trx 1 detection antibody; medical diagnostic apparatusanalytical apparatus for medical purposes and blood pressure measuring apparatus; blood analysis apparatus for diagnosis.
Publications
History of USPTO decisions and trademark events.
58 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/08/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/08/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/08/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/08/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/08/2024
GNFR
FINAL REFUSAL E-MAILED
05/08/2024
CNFR
FINAL REFUSAL WRITTEN
05/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2024
NREV
NOTICE OF REVIVAL - E-MAILED
03/26/2024
PGRR
PETITION GRANTED - RESPONSE RECEIVED
03/26/2024
APET
ASSIGNED TO PETITION STAFF
03/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
02/22/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
01/23/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
01/23/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/26/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/26/2023
CNSI
SUSPENSION INQUIRY WRITTEN
09/26/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
03/10/2023
CNSL
SUSPENSION LETTER WRITTEN
03/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2023
ALIE
ASSIGNED TO LIE
03/09/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/02/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/05/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/05/2022
CNSI
SUSPENSION INQUIRY WRITTEN
12/05/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/10/2022
GNSL
LETTER OF SUSPENSION E-MAILED
05/10/2022
CNSL
SUSPENSION LETTER WRITTEN
05/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2022
ALIE
ASSIGNED TO LIE
04/18/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/14/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/14/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/14/2021
CNSI
SUSPENSION INQUIRY WRITTEN
10/14/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/13/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/26/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/26/2021
CNSL
SUSPENSION LETTER WRITTEN
03/26/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/13/2020
GNRT
NON-FINAL ACTION E-MAILED
10/13/2020
CNRT
NON-FINAL ACTION WRITTEN
10/13/2020
DOCK
ASSIGNED TO EXAMINER
10/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens E&S HEALTHCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.